Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Indianapolis, IN
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Elkridge, MD
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Elkridge, MD
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Worcester, MA
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Traverse City, MI
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Traverse City, MI
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Raleigh, NC
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Tulsa, OK
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Warwick, RI
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Mount Pleasant, SC
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Cypress, TX
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Cypress, TX
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Waco, TX
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Salt Lake City, UT
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Sandy, UT
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Sandy, UT
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
West Jordan, UT
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  12/22/2016
mi
from
Oklahoma City, OK
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated:  1/5/2017
mi
from
Tampa, FL
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Florida Orthopaedic Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated:  1/5/2017
mi
from
Baltimore, MD
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated:  1/5/2017
mi
from
Rochester, NY
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Lattimore Orthopaedics P.C.
mi
from
Rochester, NY
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated:  1/5/2017
mi
from
Salem, OR
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Willamette Orthopedic Group LLC
mi
from
Salem, OR
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated:  1/5/2017
mi
from
Houston, TX
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Memorial Bone and Joint Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated:  1/5/2017
mi
from
Washington DC,
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
George Washington University
mi
from
Washington DC,
Click here to add this to my saved trials
Duration of Immune Response to Influenza Vaccination in Patients With RA
Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents
Status: Enrolling
Updated:  1/5/2017
mi
from
Cooperstown, NY
Duration of Immune Response to Influenza Vaccination in Patients With RA
Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents
Status: Enrolling
Updated: 1/5/2017
Bassett Healthcare Network
mi
from
Cooperstown, NY
Click here to add this to my saved trials
Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Arthroplasty
The Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Replacements Performed Within One Week
Status: Enrolling
Updated:  1/11/2017
mi
from
Jacksonville, FL
Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Arthroplasty
The Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Replacements Performed Within One Week
Status: Enrolling
Updated: 1/11/2017
Heekin Orthopedic Specialists
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated:  1/23/2017
mi
from
La Jolla, CA
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
UC San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated:  1/23/2017
mi
from
Sarasota, FL
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Sarasota Arthritis Research Center
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated:  1/23/2017
mi
from
Lansing, MI
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Justus J. Fiechtner, MD, PC
mi
from
Lansing, MI
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated:  1/23/2017
mi
from
Dallas, TX
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Metroplex Clinical Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated:  1/23/2017
mi
from
Seattle, WA
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Seattle Rheumatology Associates/Swedish Clinical Research
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated:  1/23/2017
mi
from
Palo Alto, CA
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated:  1/23/2017
mi
from
Chicago, IL
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve LDA or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective When Treating to Target
Status: Enrolling
Updated:  1/23/2017
mi
from
Aventura, FL
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve LDA or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective When Treating to Target
Status: Enrolling
Updated: 1/23/2017
AARDS Research, Inc
mi
from
Aventura, FL
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  1/30/2017
mi
from
Omaha, NE
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Heartland Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  1/30/2017
mi
from
Las Vegas, NV
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Matthew Barton, MD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  1/30/2017
mi
from
Greensboro, NC
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Triad Clinical Trials, LLC
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  1/30/2017
mi
from
Duncansville, PA
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  1/30/2017
mi
from
Plano, TX
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Clinical Investgations of Texas
mi
from
Plano, TX
Click here to add this to my saved trials
The Health Log: A Randomized Clinical Trial
The Use of a Health Management Tool in a Clinic Setting to Improve Self-Efficacy in Rheumatoid Arthritis Patients: a Randomized Clinical Trial.
Status: Enrolling
Updated:  1/31/2017
mi
from
Boston, MA
The Health Log: A Randomized Clinical Trial
The Use of a Health Management Tool in a Clinic Setting to Improve Self-Efficacy in Rheumatoid Arthritis Patients: a Randomized Clinical Trial.
Status: Enrolling
Updated: 1/31/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Anniston, AL
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Mesa, AZ
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Phoenix, AZ
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Little Rock, AR
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Beverly Hills, CA
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Covina, CA
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Covina, CA
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
La Jolla, CA
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Tustin, CA
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Upland, CA
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Colorado Springs, CO
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Danbury, CT
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Brandon, FL
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Jacksonville, FL
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated:  2/22/2017
mi
from
Miami, FL
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials